Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies

Acta Neuropathologica

Volumn 110, Issue 6, 2005, Pages 547-556

  Nakashima, Hanae ^a   Ishihara, Takeshi ^a   Suguimoto, Pilar ^a   Yokota, Osamu ^a   Oshima, Etsuko ^a   Kugo, Aki ^a   Terada, Seishi ^a   Hamamura, Takashi ^a   Trojanowski, John Q ^b   Lee, Virginia M Y ^b   Kuroda, Shigetoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Animal models; GSK 3; Lithium; Tau; Ubiquitination

Indexed keywords

AMYLOID BETA PROTEIN; LITHIUM CHLORIDE; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LONG TERM CARE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TAUOPATHY; TRANSGENIC MOUSE; UBIQUITINATION;

ANIMALS; BLOTTING, WESTERN; BRAIN; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOHISTOCHEMISTRY; LITHIUM; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; PHOSPHORYLATION; TAU PROTEINS; TAUOPATHIES; TIME FACTORS; UBIQUITIN;

EID: 28844481487     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-005-1087-4     Document Type: Article

References (38)

1. Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 98:6923-6928 10.1073/pnas.121119298
2. Belmaker RH (2004) Bipolar disorder. N Engl J Med 351:476-486 10.1056/ NEJMra035354
3. Bhat RV, Budd Haeberlein SL, Avila J (2004) Glycogen synthase kinase 3: a drug target for CNS therapies. J Neurochem 89:1313-1317 10.1111/ j.1471-4159.2004.02422.x
4. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33:95-130 10.1016/ S0165-0173(00)00019-9
5. Chalecka-Franaszek E, Chuang DM (1999) Lithium activates the serine/ threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA 96:8745-8750 10.1073/ pnas.96.15.8745
6. Chen G, Bower KA, Ma C, Fang S, Thiele CJ, Luo J (2004) Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death. FASEB J 18:1162-1164 10.1096/fj.03-0899com
7. Cleveland DW, Hwo SY, Kirschner MW (1977) Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol 116:207-225 10.1016/ 0022-2836(77)90213-3
8. David DC, Layfield R, Serpell L, Narain Y, Goedert M, Spillantini MG (2002) Proteasomal degradation of tau protein. J Neurochem 83:176-185 10.1046/j.1471-4159.2002.01137.x
9. Delobel P, Leroy O, Hamdane M, Sambo AV, Delacourte A, Buee L (2005) Proteasome inhibition and Tau proteolysis: An unexpected regulation. FEBS Lett 579:1-5 10.1016/j.febslet.2004.11.018
10. Drechsel DN, Hyman AA, Cobb MH, Kirschner MW (1992) Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol Biol Cell 3:1141-1154 1421571
11. Eldar-Finkelman H (2002) Glycogen synthase kinase 3: An emerging therapeutic target. Trends Mol Med 8:126-132 10.1016/ S1471-4914(01)02266-3
12. Greenberg SG, Davis P (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis.Proc Natl Acad Sci USA 87:5827-5831 2116006
13. Higuchi M, Ishihara T, Zhang B, Hong M, Andreadis A, Trojanowski J, Lee VMY (2002) Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Neuron 35:433-446 10.1016/ S0896-6273(02)00789-4
14. Hong M, Chen DC, Klein PS, Lee VMY (1997) Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem 272:25326-25332 10.1074/jbc.272.40.25326
15. Hongisto V, Smeds N, Brecht S, Herdegen T, Courtney MJ, Coffey ET (2003) Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3. Mol Cell Biol 23:6027-6036 10.1128/ MCB.23.17.6027-6036.2003
16. Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, Trojanowski JQ, Lee VMY (1999) Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24:751-762 10.1016/S0896-6273(00)81127-7
17. Ishihara T, Higuchi M, Zhang B, Yoshiyama Y, Hong M, Trojanowski JQ, Lee VMY (2001) Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments. J Neurosci 21:6026-6035 11487626
18. Ishihara T, Zhang B, Higuchi M, Yoshiyama Y, Trojanowski JQ, Lee VMY (2001) Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am J Pathol 158:555-562 11159192
19. Lee VMY, Trojanowski JQ (2001) Transgenic mouse models of tauopathies: prospects for animal models of Pick's disease. Neurology 56:S26-30 10.1159/000048131
20. Lee VMY, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121-1159 10.1146/annurev.neuro.24.1.1121
21. Leroy K, Boutajangout A, Authelet M, Woodgett JR, Anderton BH, Brion JP (2002) The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Acta Neuropathol 103:91-99 10.1007/s004010100435
22. Li X, Bijur GN, Jope RS (2002) Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection. Bipolar Disord 4:137-144 10.1034/ j.1399-5618.2002.40201.x
23. Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB, Faulk MW, Koch S, Glitz DA, Jolkovsky L, Manji HK (2000) Lithium increases N-acetyl-aspartate in the human brain: In vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 48:1-8 10.1016/ S0006-3223(00)00252-3
24. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK (2000) Lithium-induced increase in human brain grey matter. Lancet 356:1241-1242 10.1016/ S0140-6736(00)02793-8
25. Mudher A, Shepherd D, Newman TA, Mildren P, Jukes JP, Squire A, Mears A, Drummond JA, Berg S, MacKay D, Asuni AA, Bhat R, Lovestone S (2004) GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol Psychiatry 9:522-530 10.1038/sj.mp.4001483
26. Munoz-Montano JR, Moreno FJ, Avila J, Diaz-Nido J (1997) Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Lett 411:183-188
27. Munoz-Montano JR, Lim F, Moreno FJ, Avila J, Diaz-Nido J (1999) Glycogen synthase kinase-3 modulates neurite outgrowth in cultured neurons: possible Implications for neurite pathology in Alzheimer's disease. J Alzheimers Dis 1:361-378 12214113
28. Nakashima H, Ishihara T, Yokota O, Terada S, Trojanowski JQ, Lee VMY, Kuroda S (2004) Effects of alpha-tocopherol on an animal model of tauopathies. Free Radic Biol Med 37:176-186 10.1016/ j.freeradbiomed.2004.04.037
29. Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, Gaynor K, Wang L, LaFrancois J, Feinstein B, Burns M, Krishnamurthy P, Wen Y, Bhat R, Lewis J, Dickson D, Duff K (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci USA 102:6990-6995 10.1073/pnas.0500466102
30. Pei JJ, Tanaka T, Tung YC, Braak E, Iqbal K, Grundke-Iqbal I (1997) Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 56:70-78 8990130
31. Perez M, Hernandez F, Lim F, Diaz-Nido J, Avila J (2003) Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model. J Alzheimers Dis 5:301-308 14624025
32. Petrucelli L, Dickson D, Kehoe K, Taylor J, Snyder H, Grover A, De Lucia M, McGowan E, Lewis J, Prihar G, Kim J, Dillmann WH, Browne SE, Hall A, Voellmy R, Tsuboi Y, Dawson TM, Wolozin B, Hardy J, Hutton M (2004) CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet 13:703-714 10.1093/hmg/ddh083
33. Phiel CJ, Wilson CA, Lee VMY, Klein PS (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423:435-439 10.1038/nature01640
34. Shimura H, Schwartz D, Gygi SP, Kosik KS (2004) CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J Biol Chem 279:4869-4876 10.1074/jbc.M305838200
35. Song L, De Sarno P, Jope RS (2002) Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation. J Biol Chem 277:44701-44708 10.1074/jbc.M206047200
36. Takahashi M, Yasutake K, Tomizawa K (1999) Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons. J Neurochem 73:2073-2083 10537067
37. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 72:1858-1862 1057175
38. Yamamoto A, Lucas JJ, Hen R (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101:57-66 10.1016/S0092-8674(00)80623-6